OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 85
Healthy Volunteers: t
View:
• Adult subjects aged 21 to 85 years old
• Subjects living in Switzerland, Germany or in the UK
• Subjects that are:
• Aktiia users owning a smartphone with either iOS or Android operating system (ARMs 1 and 2); or Aktiia non-users owning a smartphone with iOS or Android operating system (ARM 3)
• Subjects agreeing to follow the study procedures.
Locations
Other Locations
Switzerland
Fully remote study- no physical investigational site
RECRUITING
Lausanne
United Kingdom
Fully remote study- no physical investigational site
RECRUITING
London
Contact Information
Primary
Pascale Vermare
pascale.vermare@aktiia.com
+41 32 552 20 52
Time Frame
Start Date: 2025-05-12
Estimated Completion Date: 2035-05-31
Participants
Target number of participants: 15000
Treatments
ARM 1 G1 Aktiia users Android
Research participants are Aktiia G1 users with Android operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with Android operating system.
ARM 2 G1 AKTIIA users iOS
Research participants are Aktiia G1 users with iOS operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with iOS operating system.
ARM 3 non-Aktiia-G1-users Android & iOS
Research participants are non-Aktiia-G1 users (they do not own an Aktiia G1 device at their inclusion in the study), located in Switzerland, Germany or UK, and owning a smartphone with either iOS or Android operating system.
Related Therapeutic Areas
Sponsors
Leads: Aktiia SA